A Study of Haematological Parameters in Patients Suffering from COVID-19 in a Tertiary Care Centre, Chennai
COVID-19 is a viral infectious disease caused by the novel severe acute respiratory syndrome Corona virus SARS-CoV-2. COVID-19 first case was reported in Wuhan, China in December 2019 and since then emerged into a global pandemic causing innumerable loss of lives around the world. One of the earliest research findings done a cross China by Guan, et al. showed that lymphocytopenia, thrombocytopenia, and leukopenia were the common haematological manifestations among COVID-19 patients. A single centre prospective observational study of 291 COVID-19 patients with laboratory confirmed infection and admitted to sree balaji medical college and hospital. In this study, among COVID-19 patient’s pancytopenia was 2.40%. 15.80% of patients had leukopenia, while 15.80% and 9.96% of patients had anaemia and thrombocytopenia. 15.46% of patients had lymphocytopenia where as 3.78% presented with leucocytosis and 8.59% had neutrophil a respectively. The lymphocyte neutrophil ratio was raised more than 3.5 in 16.84%. Thrombocytopenia and leucocytosis with sex, leukopenia with age group, anaemia with age group and sex amongst COVID-19 were the statistically significant findings present in our study. Constant analysis of COVID haematological parameters along with other investigations and clinical assessment is essential to find the changes made by the different strains of COVID-19 to guide the patients to a proper care and reduce the death rates in these patients.